Pub. 100-04 Medicare Claims Processing: New Dispensing/Supply Fee Codes for Oral Anti-Cancer, Oral Ant-Emetic, Immunosuppressive, and Inhalation Drugs
Guidance that rescinds Transmittal 394, dated December 10, 2004, and replaces it with Transmittal 396, dated December 16, 2004. The business requirements were modified (3620.12). All other information remains the same. The replacement Transmittal includes new text regarding changes to the pharmacy supply fee for certain drugs (e.g., immunosuppressive drugs, oral anti-cancer chemotherapeutic drugs), and the dispensing fees for inhalation drugs furnished through durable medical equipment.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: December 16, 2004
HHS is committed to making its websites and documents accessible to the widest possible audience, including individuals with disabilities. We are in the process of retroactively making some documents accessible. If you need assistance accessing an accessible version of this document, please reach out to the guidance@hhs.gov.
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.